RecruitingNot Applicable

Endocardial Mapping With the CoreMap EP Mapping System

United States, Czechia245 participantsStarted 2024-07-25

Plain-language summary

This is a global, multi-site, prospective, feasibility study.

Who can participate

Age range

18 Years – 80 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. Subject has persistent or long-standing persistent AF, at the discretion of the investigator (Phase 1 \& 2)
. Subject has PerAF with no history of prior AF ablation therapy (Phase 3)
. Subject is 18 to 80 years of age
. Subject has presence of AF-related symptoms and is scheduled for clinically indicated standard of care AF ablation to manage PerAF (Phase 2 or 3) or long-standing PerAF (Phase 2)
. Subject is able to provide written informed consent
. Subject is able and willing to complete all study procedures

Exclusion criteria

. Any of the following within three months of enrollment:
. Myocardial infarction (MI)
. Any surgical or percutaneous cardiac procedure including coronary intervention and cardiac ablation
. Confirmed thrombus on imaging
. Any of the following within six months of enrollment:

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Phases 1 and Phase 2 Primary Endpoint:

Timeframe: 7 days

Phase 2 and Phase 3 Primary Effectiveness Endpoint:

Timeframe: 6 and 12 months

Trial details

NCT IDNCT06529978

SponsorCoreMap Inc.

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2026-12-31

Contact for this trial

Jim Foster, SysEng

6178723908 jfoster@coremapmedical.com

View on ClinicalTrials.gov More Persistent Atrial Fibrillation trials